ciprofloxacin has been researched along with MS (Multiple Sclerosis) in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multi-resistant nosocomial urinary tract infections occurring in thirty patients with neurogenic bladder dysfunction were treated with ciprofloxacin 100 mg twice daily Early bacteriological eradication was obtained in 48." | 5.06 | Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis. ( Baert, L; van Poppel, H, 1987) |
| " The most common adverse events and pharmacodynamic effects are related to plasma concentrations." | 2.44 | A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients. ( Henney, HR; Runyan, JD, 2008) |
| "However the number of septic arthritis cases due to S." | 1.38 | [Septic arthritis of hip due to Salmonella Typhi in a patient with multiple sclerosis]. ( Altay, T; Avcı, M; Coşkuner, SA; Havuk, A; Olut, AI; Ozgenç, O; Ozsu Caymaz, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edlich, RF | 1 |
| Olut, AI | 1 |
| Avcı, M | 1 |
| Ozgenç, O | 1 |
| Altay, T | 1 |
| Coşkuner, SA | 1 |
| Ozsu Caymaz, S | 1 |
| Havuk, A | 1 |
| Henney, HR | 1 |
| Runyan, JD | 1 |
| Van Poppel, H | 3 |
| Willemen, P | 1 |
| Wegge, M | 2 |
| Kraseman, P | 1 |
| Chysky, V | 2 |
| Baert, L | 2 |
| Dammekens, H | 1 |
1 review available for ciprofloxacin and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.
Topics: Chemistry, Pharmaceutical; Ciprofloxacin; Clonidine; Dose-Response Relationship, Drug; Drug Interact | 2008 |
2 trials available for ciprofloxacin and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Antibiotic cover of transurethral maneuvers with ciprofloxacin and susceptibility behavior of pathogens in patients with neurogenic bladder.
Topics: Bacteriuria; Ciprofloxacin; Cystoscopy; Double-Blind Method; Female; Humans; Male; Microbial Sensiti | 1990 |
Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; M | 1987 |
3 other studies available for ciprofloxacin and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Guardian ad litem, a potentially expensive invitation to either the mismanagement or management of patients with cognitive disorders.
Topics: Aged; Catheters; Ciprofloxacin; Cognition Disorders; Cystostomy; Elder Abuse; Fever; Humans; Legal G | 2010 |
[Septic arthritis of hip due to Salmonella Typhi in a patient with multiple sclerosis].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Arthritis, Infectious; Bacteremia; Bursitis; Cip | 2012 |
Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis.
Topics: Anti-Infective Agents; Catheters, Indwelling; Ciprofloxacin; Cystitis; Enterobacteriaceae Infections | 1986 |